Activation of the Dmp1 promoter by oncogenic Ras or mutant HER2 have been reported [11,14,36], indicating that it is a critical mediator in RAS or HER2 induced ARF, p53 cell cycle arrest to prevent incipient cancer cells. The gene discussed is CDKN2A; the disease is cancer.